Home with TablO outcoMEs (HOME) Registry

Go Back to All Clinical Trials

Home with TablO outcoMEs (HOME) Registry

Brief description of study

This study is collecting information about the Tablo Hemodialysis System. This device has been cleared by FDA for home use and is commercially available. The Tablo device will be used per the approved intended use and the instructions for use. If you are a patient with end stage renal disease (ESRD) that is being adequately treated by maintenance dialysis and have chosen to receive in-home care with Tablo at home as part of your standard medical care. The purpose of this study is to collect medical information and your experiences using an in-home hemodialysis system called the Tablo® Hemodialysis System.

Clinical Study Identifier: s20-01031

Principal Investigator: Naveed N. Masani.

Other Investigator: James Drakakis.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies